PMI Vice President: Adoption of Smoke-Free Technologies in Africa Is Slow, Company to Step Up Promotion Efforts

Jul.09
PMI Vice President: Adoption of Smoke-Free Technologies in Africa Is Slow, Company to Step Up Promotion Efforts
Africa faces both challenges and opportunities in tobacco control, with the rollout of new technologies progressing slowly and public health requiring urgent attention. Philip Morris International (PMI) says it will continue promoting innovative technologies to accelerate the transformation of tobacco products.

Key Points:

 

·The slow adoption of new tobacco technology in Africa has raised public health concerns, with the tobacco industry interference, weak regulatory framework, and lack of public awareness slowing down technology dissemination. 

 

·Philip Morris International (PMI) has warned that delays in technology adoption could hinder disease control progress. 

 


【2Firsts News Flash】According to Nyasa Times reported on July 8th, Branislav Bibic, Vice President for Sub-Saharan Africa at PMI, expressed concern over the slow adoption of new tobacco technology in African countries during the Technovation 2025 conference in Cape Town, South Africa.

 

Bibicchi stated that delaying the adoption of new technologies will put smokers at risk of developing cancer, respiratory issues, and cardiovascular disease. He said:

 

"It is easier to introduce new technologies in developed markets because people have more funds, higher purchasing power, and more information. We know that Africa has shown good performance in adopting new technologies, but there is often a delay."

 

The unique socio-economic landscape in Africa, including high poverty and unemployment rates, makes it more susceptible to the influence of tobacco industry marketing strategies and sets barriers for implementing effective tobacco control measures. Research has shown that balancing harm reduction potential with comprehensive tobacco control strategies is a key challenge.

 

Many African countries have weak or poorly enforced tobacco control laws, allowing the tobacco industry to operate almost unchecked. Research shows that challenges remain in regulating new nicotine products such as e-cigarettes and heated tobacco products.

 

Furthermore, the lack of unified regulatory measures between different African countries has resulted in inconsistent regulation of tobacco products. Insufficient funding from governments for tobacco control programs also hinders the implementation of effective policies and public health measures.

 

He stated that this undermines efforts for tobacco control and may lead to new technologies being seen as undesirable. However, he expressed confidence in the eventual entry of new technologies into the African market and confirmed that Philip Morris International (PMI) will continue to promote these products. He said:

 

"We believe that these new technologies will also expand in sub-Saharan Africa, with Philip Morris International (PMI) playing a key role. We will continue to invest in smoke-free products, not only in developed countries but also in Africa, where greater regulation and tax progress are needed."

 

Bibiqi pointed out that industries and consumers in Africa are eager to embrace new technologies and transition away from cigarettes. He stated:

 

"We are actively engaging with the community and policymakers to share the scientific basis of smoke-free products and their potential harm reduction. We are accelerating progress through the implementation of specific product regulations. While this is not a simple process, we are making every effort to do so."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives
Morocco Lawmakers Propose Excise Taxes on Vapes, Hookah, and Nicotine Alternatives
Members of the Socialist Union of Popular Forces (USFP) have submitted amendments to Article 7 of the Finance Bill, introducing new excise taxes on e-cigarette liquids, hookah accessories, and non-tobacco nicotine products. The proposal also revises VAT exemptions and insurance tax rates to enhance fiscal fairness and revenue clarity.
Nov.11 by 2FIRSTS.ai
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
The Constitutional Court of Latvia upheld the 2025 vape-flavor ban as constitutional, rejecting appeals by Pro Vape and SIA MASS Industry. Judges said the restrictions serve a legitimate public-health purpose by protecting youth from nicotine addiction and that the social benefits outweigh business losses.
Oct.24 by 2FIRSTS.ai
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco (JT) announced that Ploom AURA has added a second limited-edition colorway, “Bronze Royal,” which will be available in limited quantities through official channels starting November 11, priced at approximately $27.3.
Nov.12 by 2FIRSTS.ai
2Firsts Observation | U.S. E-cigarette Regulation Enters Normalized Phase as Federal and State Authorities Tighten Compliance Frameworks
2Firsts Observation | U.S. E-cigarette Regulation Enters Normalized Phase as Federal and State Authorities Tighten Compliance Frameworks
In just two months, U.S. authorities seized over 7 million illegal e-cigarettes. 2Firsts’ analysis reveals a shift toward institutionalized regulation, with federal and state agencies intensifying enforcement — signaling a major reset in the world’s largest and most influential vaping market.
Oct.28
UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales
UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales
According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.
Nov.13 by 2FIRSTS.ai